69 FR 9 pg. 2123 - Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Chemosensitizing Agents Against Choroquine Resistant P. Falciparum and Methods of Making and Using Thereof
Type: NOTICEVolume: 69Number: 9Page: 2123
FR document: [FR Doc. 04-821 Filed 1-13-04; 8:45 am]
Agency: Defense Department
Sub Agency: Department of the Army
Official PDF Version: PDF Version
DEPARTMENT OF DEFENSE
Department of the Army
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Chemosensitizing Agents Against Choroquine Resistant P. Falciparum and Methods of Making and Using Thereof
AGENCY:
Department of the Army, DoD.
ACTION:
Notice.
SUMMARY:
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/849,400 entitled "Chemosensitizing Agents Against Chloroquine Resistant P. Falciparum and Methods of Making and Using Thereof," filed May 7, 2001. Foreign rights are also available (PCT/USO1/14574). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
ADDRESSES:
Commander, U.S. Army Medical Research and Materiel, Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research Technology Assessment, (301) 610-6664, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION:
A compound having the structural formula
[Federal Register graphic "EN14JA04.002" is not available. Please view the graphic in the PDF version of this document.]
or pharmaceutically acceptable salt or prodrug thereof, wherein X is a substituted or unsubstituted alkyl or a heteroatom; n is 4, 5 or 6; Y is a substituted or unsubsituted or alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or
[Federal Register graphic "EN14JA04.003" is not available. Please view the graphic in the PDF version of this document.]
wherein R1 and R2 are each independently, H, a heteroatom, substituted or unsubstituted alkyl, cycloalkl, heterocycloalkyl, aryl, or heteroaryl; and wherein each ring structure are independently substituted or unsubsituted is disclosed. Also disclosed are chemosensitizing agents and methods of modulating, attenuating, reversing, or affecting a cell's or organism's resistance to a given drug such as an antimalarial.
Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 04-821 Filed 1-13-04; 8:45 am]
BILLING CODE 3710-08-M